Home How To Use This Resource Editors and Contributors Index of Marks Useful Links
|
|
- Ross Jackson
- 6 years ago
- Views:
Transcription
1 Respond to our user survey. Back to Global Trademark Resources Home How To Use This Resource Editors and Contributors Index of Marks Useful Links Supplemental Resource Famous and Well-Known Marks: An International Analysis uniquely explores the rationale for and implementation of the protection of these exceptional trademarks. This benchmark work, available online for the first time, is an invaluable guide to the principles and practice of this evolving body of international law. INTA gratefully acknowledges the contributions of this publication's Principal Author and Editor, Frederick W. Mostert, and all of its Contributing Authors. The Supplemental Resource, accessible through the tab above, is a separate searchable database of marks that have been recognized as famous or well-known by particular jurisdictions. For additional information on how to use this resource, please click on the tab under the banner at the top of this page. You can print a full chapter or country PDF by clicking on the attachments icon (the paper clip) on the lower left side of the page view. You must print from the attachment, not the original PDF. Adobe Reader is required to view a full chapter or country PDF. You can download it here. CONTENTS Collapse All CHAPTER 1: International Recognition and Protection of Famous and Well-Known Marks II. Supranational Law A. The Distinction Between Reputation and "Well-Known Marks" B. The Degree of Recognition of the Mark C. The Extent to Which the Mark Is Used and the Duration of the Use D. The Extent and Duration of Advertising and Publicity Accorded to the Mark E. The Extent to Which the Mark Is Recognized, Used, Advertised, Registered, an Enforced Geographically or, If Applicable, Other Relevant Factors That May Determine the Mark's Geographical Reach Locally, Regionally, and Worldwide F. The Degree of Enforcement and Registration of the Mark G. The Degree of Inherent or Acquired Distinctiveness of the Mark H. The Degree of Exclusivity of the Mark and the Nature and Extent of Use of the Same or a Similar Mark by Third Parties I. The Nature of the Goods or Services and the Channels of Trade for the Goods or Services That Bear the Mark J. The Degree to Which the Reputation of the Mark Symbolizes Quality Goods K. The Extent of the Commercial Value Attributed to the Mark A. Marks That Are "Famous," "Well-Known," or That Enjoy a "Reputation" B. Additional Parameters C. Caveat: Famous and Well-Known Marks Only
2 A. The Element of Bad Faith in Proceedings for the Refusal of an Application or for the Cancellation of a Registration and for Injunctive Relief B. The Element of Bad Faith C. Bad Faith as a Single Factor D. Good Faith Adoption A. Confusion of Business Connection or Sponsorship B. Trademark Dilution C. Defense in Dilution Cases D. Commercial Magnetism as a Ius In Se VII. Remedies B. Refusal of an Application or Cancellation of a Registration That Conflicts With a Famous or Well-Known Mark C. Injunctive Relief Against the Use of a Mark That Conflicts With a Famous or Well-Known Mark D. Damages VIII. Customs: Protection of Famous and Well-Known Marks at the Border B. Supranational Law-Recognizing Changes C. National Law IX. Counterfeits: The Protection of Famous and Well-Known Marks Against Piracy B. The Nature and Extent of the Trademark Counterfeiting Problem C. Laws Relating to Trademark Counterfeiting, Enforcement and Famous and Well-Known Mark Protection D. A Practical Trademark Enforcement Program for Famous and Well-Known Mark Owners 1. Centralized Command 2. Effective and Experienced Outside Counsel and Private Investigators 3. An Anticounterfeiting Policy and Plan 4. Close Coordination With the Trademark Registration Program 5. Careful Planning at the Regional and National Level and Budgetary Considerations 6. Using Anticounterfeiting Technologies 7. Use of Databases and Control of Information 8. Use of Appropriate Enforcement Weapons 9. Working with Other Intellectual Property Rights Holders 10. Publicity and Public Relations 11. Evidence of Fame and Reputation 12. Assessment and Recidivism E. Conclusion X. Conclusion CHAPTER 2: Protection of Other Famous and Well-Known Indicators of Origin I. Protection of Famous and Well-Known Trade Names B. Supranational Law C. Criteria D. Parameters 1. General 2. Local Use as a Precondition for Protection
3 3. Licensing a Trade Name Across Borders E. Protection in the Absence of Competition F. Bad Faith and Damages II. Protection of Famous and Well-Known Geographical Indications B. Supranational Law C. Criteria D. Parameters E. Protection on Non-Competing Goods F. Bad Faith and Damages III. Protection of Famous and Well-Known State Emblems IV. Trade Dress: Protection of Famous and Well-Known Get-Up B. Supranational Law C. The Criteria: When Is a Trade Dress or Get-Up "Famous" or "Well-Known"? D. Parameters of Famous and Well-Known Trade Dresses and Get-Up 1. The Problem of Functionality a. Utilitarian Functionality b. Aesthetic Functionality 2. Labeling E. Protection on Non-Competing Goods F. Bad Faith and Damages 1. The Significance of Bad Faith Copying 2. Damages V. Public Figures and Celebrities: Protection of Famous and Well-Known Figures B. Supranational Law C. Criteria D. Parameters 1. Personality Rights 2. Registered Trademarks 3. Unfair Competition and Passing Off 4. Miscellaneous Rights E. Protection in the Absence of Competition F. Relevance of Bad Faith and Damages G. Conclusion VI. Internet: Protection of Famous and Well-Known Domain Names 1. The Magnetism of Famous Marks on the Internet for Traffic and Piracy B. Brief History of the Treatment of Famous Marks on the Internet 1. Mid-1990s: The Initial Response - Limitations of Existing Statutes Pre-Cybersquatting Laws 2. The Legislative Response to Cybersquatting C. Survey of Existing Famous Mark Protection 1. Supranational Law 2. National Legislation and Dispute Resolution Policies
4 D. Discussion and Open Issues 1. Special Role of Bad Faith 2. Fair Use Issues 3. Use of Famous and Well-Known Marks as Keywords 4. Protection of Personal Names of Famous Individuals 5. Extraterritorial Effect of ACPA - The Ability of Non-U.S. Marks to Utilize ACPA 6. Enhanced In Rem Powers over Domain Names 7. Protection of Famous Marks in Social Media E. Conclusion and Predictions CHAPTER 3: Recognition and Protection of Famous and Well-Known Marks by Jurisdiction ARGENTINA A. General B. Notoriety as a Distinctive Element C. Dilution D. Misappropriation and Unjust Enrichment AUSTRALIA A. Refusal or Cancellation B. Prohibition of Use of Confusing Marks VIII. Conclusion BENELUX A. Supranational Law B. Previous Benelux Law C. Current Benelux Law
5 VIII. Conclusion BRAZIL CANADA A. Refusal or Cancellation of Registration B. Prohibition on Use of Confusing Marks A. Degree of Notoriety or Recognition of the Mark B. Geographical Extent of Making-Known IV. Parameters of Well-Known Marks VII. Section 22: Depreciation of Goodwill VIII. Damages CHINA A. Supranational Law B. National Law 1. The 1996 Regulations 2. Current Trademark Law 3. The 2003 Regulations III. The Criteria: When Is a Mark "Well-Known"? IV. Parameters of Well-Known Marks A. Procter & Gamble v. Shanghai Chengxuan Intelligent Tech Development Limited B. E.I. Dupont De Nemours and Company v. Beijing Cinet Information Limited C. Starbucks v. Shanghai Xinbake Coffee Shops Limited V. Protection of Well-Known Marks and the Element of Bad Faith VI. Protection of Well-Known Marks on Non-Competing Goods VIII. Conclusion FRANCE A. The Paris Convention B. The TRIPS Agreement
6 C. The European Trademark Harmonization Directive A. Well-Known Trademarks B. The Famous Trademark (or Mark of Renown) A. Well-Known Trademarks B. Famous Trademarks A. The Acquisition of a Right: Article 6bis of the Paris Convention B. Other Consequences of Well-Known Status A. The Case Considered B. International Discussion C. The Early Cases D. The Current Positive French Law E. Jurisprudence GERMANY II. International and National Law III. The Criteria: When is a Mark "Famous," Reputed" or "Well-Known"? A. Court Rulings Prior to the Coming Into Force of the German Trademark Act on 1 January 1995 B. The Concept of Reputed in the Reputed Marks in German Trademark Law IV. Parameters of Famous, Reputed and Well-Known Marks A. Market Recognition B. Well-Known Mark C. Marks Having a Reputation in Germany D. amous Marks E. The Determination of the Level of Recognition V. Protection of Reputed Marks and the Element of Bad Faith VI. Protection of Reputed Marks on Non-Competing Goods A. The Likelihood of Confusion and the Similarity of the Goods and Services 1. Assessment of the Likelihood of Confusion Pursuant to Section 14(2) (No. 2) MarkenG 2. Similarity of Goods and Services B. Exploitation of Reputation and Tarnishment of Reputation (Dilution) 1. Identical or Similar Goods and Services 2. Identical or Similar Marks 3. The Exploitation of or Detriment to Distinctiveness or Reputation Without Due Cause by Unfair Means a. Exploitation of Reputation b. Exploitation of Distinctive Character c. Detriment to Reputation (Tarnishment of Reputation) d. Detriment to Distinctive Character (Tarnishment of Distinctiveness) C. Use as Trademark VIII. Conclusion
7 INDIA A. Trademarks B. Trade Names C. Trade Dress D. Evidence VII. Remedies VIII. Time Factor in Infringement Cases IX. Conclusion ITALY III. The Criteria and Parameters: When Is a Mark "Famous" or "Well-Known"? IV. Protection of Famous and Well-Known Marks A. Civil Protection B. Criminal Protection V. Damages VI. Conclusion JAPAN VIII. Protection of Famous and Well-Known Marks Against Cybersquatting IX. Conclusion MEXICO III. The Criteria: When Is a Mark "Well-Known"? RUSSIAN FEDERATION
8 A. Treaties and Agreements 1. Paris Convention; TRIPS Agreement 2. Multilateral (European Union-Russian Federation) (1997) 3. Bilateral (USA-Russian Federation) a. Agreement on Trade Relations (1992) b. Bilateral Investment Treaty (1992) B. National Law 1. Protection of Well-Known Marks - Background a. Trademark Law; Examination Guidelines b. Cases 1. JURASSIC PARK (copyright) 2. GROLSCH (trade name) 2. Protection of Well-Known Marks - Current SINGAPORE III. The Criteria: When Is a Mark "Well-Known"? A. Statutory Definition of a "Well-Known" Mark B. Concept of "Well-Known" in the Context of the Tort of Passing-Off C. Conclusion: "Overall Commercial Impression" and "Totality of the Evidence" A. Protection Under the Trade Marks Act B. Protection Under the Geographical Indications Act C. Protection Under the Tort of Passing-Off D. Protection of Well-Known Marks as Domain Names A. Significance of Bad Faith Under the Trade Marks Act B. Significance of Bad Faith Under the Geographical Indications Act C. Significance of Bad Faith in Passing-Off Cases D. Significance of Bad Faith in Domain Name Cases E. Bad Faith and Interlocutory Relief VI. Limitations on the Protection of Well-Known Marks VII. Future Developments SOUTH AFRICA A. Refusal or Cancellation of Registration B. Prohibition of Use III. The Criteria: When is a Mark "Famous" or "Well-Known"?
9 SPAIN III. The Criteria and Parameters: When Is a Mark "Famous" or "Well-Known"? A. Degree of Trademark Recognition B. Extent and Duration of Trademark Use C. Extent and Duration of Promotion of the Mark D. Geographic Area in Which a Trademark Is Recognized, Used, Advertised, Registered, and Defended and Other Factors for Determining Whether a Trademark Has Local, Regional or Worldwide Significance E. Degree of Inherent or Acquired Distinctiveness of Trademarks F. Degree of Trademark Exclusivity and Nature and Extent of Use of the Same or Similar Marks by Third Parties G. Nature of the Goods or Services and of the Channels of Trade for the Goods or Services Covered by a Trademark H. On Whether Well-Known Character and Renown Are the Same as a Reputation as a Symbol of Product Quality I. The Importance of a Trademark's Commercial Value I A. Bad Faith as a Determining Factor in Refusal of Registration B. Bad Faith as a Cause of Invalidity of a Registration C. Bad Faith as Grounds for Claiming Ownership of a Registration D. Bad Faith and Dolus as Elements of Wrongdoing (Particularly Criminal Wrongdoing) in the Infringement of Registered Trademark Rights V. Protection of Famous and Well-Known Marks on Non-Competing Goods A. Possible Business Connection or Sponsorship B. Taking Unfair Advantage of the Well-Known Status or Renown C. Protection Against Dilution of and Detriment to Well-Known and Famous Trademarks VI. Remedies A. Applications for Conflicting Marks Filed by Third Parties B. Conflicting Third-Party Registrations C. Third-Party Acts Infringing Rights That Do Not Involve the Register of Trademarks D. Damages E. Injunctive Relief VII. Customs Protection for Famous and Well-Known Marks VIII. Protection of Famous and Well-Known Trade Names IX. Conclusion UNITED KINGDOM A. The Terms "Famous Mark" and "Well-Known Mark" A. Relevant Supranational Agreements and Laws B. Article 6bis of the Paris Convention as Applied in the United Kingdom C. The TRIPS Agreement D. The Community Trade Mark III. The Criteria: When is a Mark "Famous" or "Well-Known"?
10 VIII. Conclusion UNITED STATES A. Infringement Proceedings B. Opposition or Cancellation Proceedings A. Confusion of Business Connection or Sponsorship B. Dilution C. Commercial Magnetism as a Ius In Se VIII. Conclusion A. Right of Publicity B. Color Marks and Product Configurations C. Customs D. Anti-Counterfeiting Seizures E. Residual Goodwill of Disused Famous Marks Disclaimer All information provided by the author and contributors of this Supplemental Resource to Famous and Well-Known Marks, An International Analysis is provided as a source of general information on trademark and related intellectual property issues. In legal matters, no publication whether in written or electronic form can take the place of professional advice given with full knowledge of the specific circumstances of each case and proficiency in the laws of the relevant country. While efforts have been made to ensure the accuracy of the information in this resource, it should not be treated as the basis for formulating business decisions without professional advice. No responsibility is accepted for the accuracy, completeness or relevance to the user's purpose of the information. Those using it for whatever purposes are advised to verify it with the relevant government department, case reporters or other sources. The author and contributors and the International Trademark Association therefore disclaim any liability however arising, including liability for negligence, errors or omissions, for any loss resulting from the use of, or reliance upon the information. Readers are advised to seek the assistance of their own expert legal counsel and other advisors with respect to any legal questions they may have relating to matters covered in this resource. We emphasize that trademark and related intellectual property laws vary from country to country, and between jurisdictions within some countries. The information included in this resource will not be relevant or accurate for all countries or states. Copyright International Trademark Association, 655 Third Avenue, 10th Floor, New York, NY USA phone +1 (212) fax +1 (212) memberservices@inta.org
Home How To Use This Resource Editors and Contributors Index of Marks Useful Links
Respond to our user survey. Back to Global Trademark Research Home How To Use This Resource Editors and Contributors Index of Marks Useful Links Supplemental Resource Famous and Well-Known Marks: An International
More informationArticle 2.4.f. BCIP describes, by way of example, two bad faith situations :
AIPPI 2017 Study Question - Bad faith trademarks Part I. Current law and practice, Repeat filings Q1) Does your Group's current law provide for an action against the application or registration for a trademark
More informationRe: Bill S-5, An Act to amend the Tobacco Act and the Non-smokers Health Act and to make consequential amendments to other Acts
655 Third Avenue, 10th Floor, New York, NY 10017-5646, USA t: +1-212-642-1776 f: +1-212-768-7796 inta.org esanzdeacedo@inta.org The Honorable Kelvin Kenneth Ogilvie Chair Standing Committee on Social Affairs,
More informationAIPPI Study Question - Bad faith trademarks
Study Question Submission date: May 8, 2017 Sarah MATHESON, Reporter General Jonathan P. OSHA and Anne Marie VERSCHUUR, Deputy Reporters General Yusuke INUI, Ari LAAKKONEN and Ralph NACK, Assistants to
More informationBret J. Danow. Partner New York p Practices. Industries. Recognition. Advisories. Articles.
Bret J. Danow Partner bret.danow@kattenlaw.com New York p +1.212.940.6365 Practices FOCUS: Intellectual Property Advertising, Marketing and Promotions Trademark Licensing and Strategy Intellectual Property
More informationEU-China Workshop on Trademark Law
EU-China Workshop on Trademark Law 13 May 2011 - Diqing (Yunnan Province) Marc L. Holtorf / 郝韬福 Topic I - Trademark use and intention to use as requirement for trademark registration Overview Principles
More informationPlain Packaging and Intellectual Property Rights. Cheng Tan, Head of Trade Marks
Plain Packaging and Intellectual Property Rights Cheng Tan, Head of Trade Marks chengtan@innovatelegal.co.uk Plain Packaging? Plain Packaging Plain Packaging WHO Framework Convention on Tobacco Control
More informationCounterfeit Medicinal Products. FINLAND Roschier, Attorneys Ltd.
Counterfeit Medicinal Products FINLAND Roschier, Attorneys Ltd. CONTACT INFORMATION Mikael Segercrantz Robert Hagelstam Roschier, Attorneys Ltd. Keskuskatu 7 A 00100 Helsinki, Finland 358.20.506.6000 mikael.segercrantz@roschier.com
More informationPresentation: Philip G. Hampton, II Haynes and Boone, LLP (202) September 14, 2017
Presentation: Philip G. Hampton, II Haynes and Boone, LLP (202) 654-4533 September 14, 2017 What is a Trademark? A trademark is any word, product name, symbol or device that identifies the goods or services
More informationNobelDesign 1.3 Installation guide
NobelDesign 1.3 Installation guide 2 NobelDesign 1.3 Installation guide // English Disclaimer of liability: This product is part of an overall concept and may only be used in conjunction with the associated
More informationAgile Product Lifecycle Management for Process
Nutrition Surveillance Management User Guide Release 5.2.1 Part No. E13901-01 September 2008 Copyrights and Trademarks Copyright 1995, 2008, Oracle Corporation and/or its affiliates. All rights reserved.
More informationAGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)
AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION (Moscow, 23 December 2014) Member States of the Eurasian Economic Union, hereinafter referred
More informationTamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
More informationSTATEMENT OF POLICY REGARDING MEDICAL MARIJUANA AND OSTEOPATHIC PHYSICIANS APPROVED SEPTEMBER 9, 2014
MEMBERS: Ronald Hedger, D.O President NEVADA STATE Ricardo Almaguer, D.O BOARD OF OSTEOPATHIC MEDICINE Vice President 901 American Pacific, Suite 180 James Anthony, D.O., J.D., M.B.A Henderson, NV 89014
More informationAlcohol marketing: Overview of the landscape
Alcohol marketing: Overview of the landscape David H. Jernigan PhD Center on Alcohol Marketing and Youth Department of Health, Behavior and Society Johns Hopkins Bloomberg School of Public Health Alcohol
More informationSPECIAL DISCLAIMER FOR INTERPRETING SERVICES INVOLVING CALLS TO EMERGENCY SERVICE PROVIDERS (911/E911), OR LEGAL, MEDICAL OR MENTAL HEALTH ISSUES
SPECIAL DISCLAIMER FOR INTERPRETING SERVICES INVOLVING CALLS TO EMERGENCY SERVICE PROVIDERS (911/E911), OR LEGAL, MEDICAL OR MENTAL HEALTH ISSUES Governing Language. The English language version of this
More informationThird Seminar on Bad Faith TM Filings. Ignacio de Medrano Caballero, OHIM TM5, Tokyo, 1 March 2016
Third Seminar on Bad Faith TM Filings Ignacio de Medrano Caballero, OHIM TM5, Tokyo, 1 March 2016 OUTLINE 01 02 03 04 Bad Faith as Invalidity Ground The Notion of Bad Faith European Case Law Bad Faith
More informationModel Intervention for Students with Substance Abuse Problems Act
Model Intervention for Students with Substance Abuse Problems Act MODEL INTERVENTION FOR STUDENTS WITH SUBSTANCE ABUSE PROBLEMS ACT Table of Contents G-103 Policy Statement G-105 Highlights Section One
More informationBad faith trademark filing: a theoretical perspective
Bad faith trademark filing: a theoretical perspective Souichirou Kozuka Gakushuin University 2016/3/1 TM5 - Seminar on Bad Faith Filing 1 Looking into the history The saga of Tokyo Gas case (SC 29 Sept.
More informationMore information at
Report Information More information at https://www.htfmarketreport.com/reports/1288313 Global Homeopathic Products Market Professional Survey Report 2018 Report Code: HTF1288313 Pages: 111 Price: 1-User
More informationIN THE UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WISCONSIN
IN THE UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WISCONSIN ULTRATEC, INC. and CAPTEL, INC., v. Plaintiffs, SORENSON COMMUNICATIONS, INC. and CAPTIONCALL, LLC, Defendants. Civil Action No.: 14-cv-66
More informationGENERAL TERMS AND CONDITIONS WCO PUBLICATIONS
Version 1.0 GENERAL TERMS AND CONDITIONS WCO PUBLICATIONS These General Terms and Conditions govern all sales of Publications, on paper and/or in digital format whether directly at the Sales Counter or
More informationDetails of Authorised Personnel
Details of Authorised Personnel This form is to be used to register authorised personnel to act on behalf of your entity via the FishServe website and through the use of paper applications, documents and
More informationWhy More Chinese Businesses Are Choosing the BVI for Offshore Investment: A Move To Quality
Page printed from: https://www.chinalawandpractice.com/2019/02/21/why-morechinese-businesses-are-choosing-the-bvi-for-offshore-investment-a-move-toquality/?printer-friendly Why More Chinese Businesses
More informationNobelProcera Implant Bar Overdenture complete range of fixed and removable solutions.
NobelProcera Implant Bar Overdenture EXPERIENCE THE NEW WORLD OF CAD/CAM DENTISTRY 2 NobelProcera Implant Bar Overdenture NobelProcera Implant Bar Overdenture complete range of fixed and removable solutions.
More informationDrug and Alcohol Management within the workplace
Drug and Alcohol Management within the workplace Introduction A business of any size can experience issues relating to drug and alcohol misuse at some point with their employees. It has become a growing
More informationWhole Grain and High Fiber - Global Market Outlook ( )
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Whole Grain and High Fiber - Global Market Outlook (2015-2022) Whole Grain and High Fiber - Global Market Outlook
More informationCase 2:12-cv KJM-GGH Document 1 Filed 07/02/12 Page 1 of 9 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF CALIFORNIA. (Sacramento Division)
Case :-cv-0-kjm-ggh Document Filed 0/0/ Page of PAUL W. REIDL (State Bar No. ) Law Office of Paul W. Reidl Eagle Trace Drive Half Moon Bay, CA 0 Telephone: (0) 0-0 Email: paul@reidllaw.com Attorney for
More informationTrauma xviv7.3-png COMMOOIES Of age* tlietotirt. Memorandum of Understanding. between. American Red Cross San Diego Imperial Counties Chapter.
Memorandum of Understanding between American Red Cross San Diego Imperial Counties Chapter and San Diego EMDR Trauma Recovery Network Trauma xviv7.3-png COMMOOIES Of age* tlietotirt 111!' American Red
More informationDiabetic Retinopathy Treatment - Global Market Outlook ( )
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Diabetic Retinopathy Treatment - Global Market Outlook (2015-2022) Diabetic Retinopathy Treatment - Global Market
More informationPyroMark Q24 CpG MGMT Handbook
December 2009 PyroMark Q24 CpG MGMT Handbook For quantification of CpG methylation in region +17 to +39 in the MGMT gene Sample & Assay Technologies QIAGEN Sample and Assay Technologies QIAGEN is the leading
More informationORDINANCE NO
ORDINANCE NO. 01-2017 AN ORDINANCE OF THE CITY COUNCIL OF THE CITY OF SEMINOLE, FLORIDA, REGARDING MEDICAL CANNABIS; IMPOSING A TEMPORARY MORATORIUM ON THE SALE OF MEDICAL CANNABIS AND ON THE ESTABLISHMENT
More informationWHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC,
WHO/NMH/PND/7.4 WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 207 Monitoring tobacco use and prevention policies Executive summary fresh and alive World Health Organization 207 Some rights reserved. This
More informationTHIS OPINION IS A PRECEDENT OF THE TTAB
THIS OPINION IS A PRECEDENT OF THE TTAB Mailed: September 23, 2010 UNITED STATES PATENT AND TRADEMARK OFFICE Trademark Trial and Appeal Board In re HerbalScience Group, LLC Serial No. 77519313 Jennifer
More informationIllinois Supreme Court. Language Access Policy
Illinois Supreme Court Language Access Policy Effective October 1, 2014 ILLINOIS SUPREME COURT LANGUAGE ACCESS POLICY I. PREAMBLE The Illinois Supreme Court recognizes that equal access to the courts is
More informationCase 1:09-cv RMB-AMD Document 1 Filed 08/12/09 Page 1 of 6 PageID: 1
Case 1:09-cv-04115-RMB-AMD Document 1 Filed 08/12/09 Page 1 of 6 PageID: 1 John E. Flaherty Jonathan M.H. Short McCARTER & ENGLISH, LLP Four Gateway Center 100 Mulberry Street Newark, New Jersey 07102-4096
More informationAlberta - US Comparator: Standard-Making and Enforcement Functions
Alberta - US Comparator: Standard-Making and Enforcement Functions Current Reliability Standards Below is a link to current reliability standards in Alberta: http://www.aeso.ca/rulesprocedures/17006.html
More informationCase 4:16-cv ALM Document 1 Filed 02/29/16 Page 1 of 11 PageID #: 1 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS SHERMAN DIVISION
Case 4:16-cv-00140-ALM Document 1 Filed 02/29/16 Page 1 of 11 PageID #: 1 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS SHERMAN DIVISION GLAXO GROUP LIMITED and GLAXOSMITHKLINE CONSUMER HEALTHCARE
More informationIMPLANTABLE MAGNETIC TRANSCUTANEOUS BONE CONDUCTION HEARING SYSTEM REIMBURSEMENT CODING GUIDE
IMPLANTABLE MAGNETIC TRANSCUTANEOUS BONE CONDUCTION HEARING SYSTEM REIMBURSEMENT CODING GUIDE This document provides general reimbursement information to assist in obtaining coverage and reimbursement
More informationSmoke-Free Campus Guidelines
Smoke-Free Campus Guidelines University Nondiscrimination Statement Iowa State University does not discriminate on the basis of race, color, age, religion, national origin, sexual orientation, gender identity,
More informationTrademark Use Guidelines for Certified Products and Related Advertising
Trademark Use Guidelines for Certified Products and Related Advertising Version 2.0. Updated March 2017 2017 CSA Group 1 Introduction CSA Group has developed a significant reputation and goodwill in its
More informationHRM Series PCB Power Relays
Features: SPCO contacts. Sealed to allow washing after flow soldering. Specifications: Coil Data: Nominal Voltage Nominal Power consumption : 3V dc to 24V dc. : 540mW to 720mW. Contact Data: Contact Arrangement
More informationHealth (Tobacco, Nicotine etc. and Care)(Scotland) Bill. Japan Tobacco International (JTI)
Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill Organisation name Japan Tobacco International (JTI) Japan Tobacco International (JTI) is part of the Japan Tobacco group (JT Group) of companies,
More informationWe are seeking to supply governments and private parties with affordable versions of drugs to treat HCV.
March 18, 2015 Mr. Gregg Alton Executive Vice President, Corporate and Medical Affairs Gilead Sciences 333 Lakeside Drive Foster City, CA 94404 Via Email: gregg.alton@gilead.com Re: Request for license
More informationCYCLOTRONS WORLD MARKET REPORT & DIRECTORY EDITION TOC and Summary USED IN NUCLEAR MEDICINE MARKET DATA, COMPANIES PROFILES.
CYCLOTRONS USED IN NUCLEAR MEDICINE WORLD MARKET REPORT & DIRECTORY MARKET DATA, COMPANIES PROFILES TOC and Summary EDITION 2015 A report written by Paul-Emmanuel Goethals & Richard Zimmermann Page 1/5
More information2015 U.S. Supplements/OTC/Rx Consumer Research Study
2015 U.S. Supplements/OTC/Rx Consumer Research Study Since 2005, NMI s bi-annual consumer research study devoted to understanding consumer attitudes and behaviors related to dietary supplements/otc/rx
More informationChemical compatibility of the Pall QPoint TM Docking Station - Tap Assembly with common surface disinfectants
Technical Report.78a Chemical compatibility of the Pall QPoint TM - Tap Assembly with common surface disinfectants QPoint - More than Filtration .0 Background The Pall QPoint Tap Water Filter Assembly
More informationNitrazepam. Nitrazepam Tablets TAJ GROUP PHARMACEUTICAL B U S I N E S S. Generics. Active Ingredients: Each tablet contains 10 mg Nitrazepam
Nitrazepam, Nitrazepam India, Nitrazepam manufacturers India, side effects Nitrazepam manufacturers, Taj Pharma India, Nitrazepam overdose, Nitrazepam drug, Nitrazepam composition, Manufacturing Pharmaceutical,
More informationMEMBER SHARE A Pastoral Medical Association - Private Membership Program MEMBER SHARE AGREEMENT (MSA)
MSA P MEMBER SHARE A Pastoral Medical Association - Private Membership Program MEMBER SHARE AGREEMENT (MSA) I, the undersigned applicant for the value, benefits and mutual promises herein, do hereby apply
More informationIN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO UNITED CANNABIS CORPORATION. Plaintiff, PURE HEMP COLLECTIVE INC.
Civil Action No: IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO UNITED CANNABIS CORPORATION a Colorado Corporation Plaintiff, v. PURE HEMP COLLECTIVE INC., a Colorado Corporation Defendant.
More informationContinuous Renal Replacement Therapy (CRRT) - Global Market Outlook ( )
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Continuous Renal Replacement Therapy (CRRT) - Global Market Outlook (2015-2022) Continuous Renal Replacement Therapy
More informationGlobal EHS Resource Center
Global EHS Resource Center Understand environmental and workplace safety requirements that affect your global operations. 800.372.1033 bna.com/gelw Global EHS Resource Center This comprehensive research
More informationTHE OPTICAL SOCIETY ONLINE JOURNALS SINGLE SITE LICENSE AGREEMENT
THE OPTICAL SOCIETY ONLINE JOURNALS SINGLE SITE LICENSE AGREEMENT BY THIS AGREEMENT between The Optical Society ( OSA ) and the named below ( Licensee ), OSA grants to Licensee access to the OSA online
More informationCase 2:15-cv SRC-CLW Document 9 Filed 02/04/16 Page 1 of 19 PageID: 246
Case 2:15-cv-08180-SRC-CLW Document 9 Filed 02/04/16 Page 1 of 19 PageID: 246 Elvin Esteves Charles H. Chevalier J. Brugh Lower GIBBONS P.C. One Gateway Center Newark, New Jersey 07102 Tel: (973) 596-4500
More informationRADIESSE Volumizing Filler E-Media Kit Terms of Use PERMISSION TO USE MERZ AESTHETICS COPYRIGHTED MATERIAL AND TRADEMARKS
RADIESSE Volumizing Filler E-Media Kit Terms of Use PERMISSION TO USE MERZ AESTHETICS COPYRIGHTED MATERIAL AND TRADEMARKS For good and valuable consideration, the receipt and sufficiency of which is hereby
More informationWHO FCTC: Text, Commitments, and Timelines: Gemma Vestal, JD, MPH, MBA, BSN. Article 15: Illicit Trade in Tobacco Products
Section B Supply Reduction: Articles 15 17 Article 15: Illicit Trade in Tobacco Products This area is one in which country-level efforts are necessary, but insufficient due to the transnational nature
More informationIssue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES
Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES CONTENTS
More informationDeath Threats and Violence
Death Threats and Violence Stephen J. Morewitz Death Threats and Violence New Research and Clinical Perspectives Stephen J. Morewitz San Francisco, California Tarzana, California Buffalo Grove, Illinois
More informationGlobal Hearing Aids Market (by Devices, Implant Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and Forecast to 2022
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Hearing Aids Market (by Devices, Implant Types, OTC Amplifiers, Diagnostic Instruments), Sales Volume, Company
More informationApril 11, :00 a.m. 11:30 a.m. Red Rock Casino Las Vegas, NV By Peter Quinter.
April 11, 2014 10:00 a.m. 11:30 a.m. Red Rock Casino Las Vegas, NV By Peter Quinter Intellectual Property Rights: How to Detect and Avoid the Scammers Peter Quinter, Attorney Customs & International Trade
More informationWhat if someone complains about me? A guide to the complaint process
What if someone complains about me? A guide to the complaint process Introduction The purpose of the licensed building practitioner scheme is to set performance standards for building practitioners and
More informationSMOKING REGULATIONS IN THE WORKPLACE
SMOKING REGULATIONS IN THE WORKPLACE 1. Introduction The ban on smoking in the workplace comes into effect on Monday March 29 th 2004. This bulletin outlines the new legislation that prohibits and restricts
More informationRe: Bayer s false and deceptive marketing for its Men s Multis for prevention of cancer
June 18, 2009 VIA REGULAR MAIL AND FAX TO 973-254-4853 Gary S. Balkema, President Consumer Care Division Bayer HealthCare LLC 36 Columbia Rd Morristown, NJ 07962-1910 Re: Bayer s false and deceptive marketing
More informationCOMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS
COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS 2016-2017 Introduction This summary provides an overview of the activities carried out by
More informationOFFICIAL STATE BULLETIN
No. 280 Saturday 18 November 2017 Sec. I. Page 111191 I. GENERAL PROVISIONS HEAD OF STATE 13277 Royal Decree-Law 17/2017, of 17 November, amending Law 28/2005, of 26 December, on health measures against
More informationGENERAL INFORMATION AND INSTRUCTIONS
NON-PARTICIPATING MANUFACTURER CERTIFICATION FOR LISTING ON OREGON DIRECTORY GENERAL INFORMATION AND INSTRUCTIONS Who is required to file this Certification? Any tobacco product manufacturer who is a non-participating
More informationDIVISION OF PUBLIC & BEHAVIORAL HEALTH BUREAU OF HEALTH CARE QUALITY AND COMPLIANCE LCB File No. R Informational Statement per NRS 233B.
DIVISION OF PUBLIC & BEHAVIORAL HEALTH BUREAU OF HEALTH CARE QUALITY AND COMPLIANCE LCB File No. R120-16 Informational Statement per NRS 233B.066 1. A clear and concise explanation of the need for the
More informationCOMMISSION IMPLEMENTING DECISION. of
EUROPEAN COMMISSION Brussels, 26.7.2016 C(2016) 4592 final COMMISSION IMPLEMENTING DECISION of 26.7.2016 concerning national provisions notified by Finland prohibiting the placing on the market of certain
More informationPLEASE NOTE. For more information concerning the history of this Act, please see the Table of Public Acts.
PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to August 20, 2016. It is intended for information and reference purposes only. This
More informationThese Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017.
Rules of Membership 1. Introduction These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017. The previously published
More informationCase M.8320-BUPA / OASIS. REGULATION (EC) No 139/2004 MERGER PROCEDURE. EUROPEAN COMMISSION DG Competition
EUROPEAN COMMISSION DG Competition Case M.8320-BUPA / OASIS Only the English text is available and authentic. REGULATION (EC) No 139/2004 MERGER PROCEDURE Article 4(4) Date: 3.2.2017 EUROPEAN COMMISSION
More informationAFFILIATION PROGRAM AGREEMENT
AFFILIATION PROGRAM AGREEMENT This AFFILIATION PROGRAM AGREEMENT (this Agreement ) is made and entered into by and between FACULTY PHYSICIANS & SURGEONS OF LLUSM dba LOMA LINDA UNIVERSITY FACULTY MEDICAL
More informationRules of Procedure for Screening and Hearing Meetings
Page: 1 of 15 SYNOPSIS: The purpose of this document is to provide rules of procedure for Screening and Hearing meetings conducted pursuant to the City s Parking Administrative Monetary Penalties By-law
More informationLEGISLATION AND USE OF TRIPS AGREEMENTS. BY ALLAN MALECHE KENYA LEGAL ÐICAL ISSUES NETWORK (KELIN) or
LEGISLATION AND USE OF TRIPS AGREEMENTS BY ALLAN MALECHE KENYA LEGAL ÐICAL ISSUES NETWORK (KELIN) amaleche@kelinkenya.org or amaleche@gmail.com OUTLINE OF PRESENTATION Background The TRIPS Agreement
More informationSTAFF REPORT City of Lancaster NB 2
STAFF REPORT City of Lancaster NB 2 12/13/16 MVB Date: December 13, 2016 To: From: Subject: Mayor Parris and City Council Members Mark V. Bozigian, City Manager Allison E. Burns, City Attorney Ordinance
More informationInvestment in MGC Pharmaceuticals
Investment in MGC Pharmaceuticals Investor Presentation May 2015 Disclaimer This presentation has been prepared by Erin Resources Limited ( Company ). It does not purport to contain all the information
More informationORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL
PROVINCE OF BRITISH COLUMBIA ORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL Order in Council No. 542, Approved and Ordered October 5, 2018 Executive Council Chambers, Victoria On the recommendation of the
More informationCase 2:17-cv Document 1 Filed 10/30/17 Page 1 of 10
Case :-cv-0 Document Filed 0/0/ Page of 0 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON AT SEATTLE 0 ANDREA SCHMITT, on her own behalf, and on behalf of all similarly situated individuals,
More informationBackground COUNTERFEITING DRUGS IS MURDER CURRENT NATIONAL LEGISLATIVE RESPONSES. 8-15% of global pharmaceutical sales is counterfeit
COUNTERFEITING DRUGS IS MURDER CURRENT NATIONAL LEGISLATIVE RESPONSES Michael H. Anisfeld Globepharm Consulting, USA Michael H. Anisfeld Globepharm Consulting 313 Pine Street Deerfield IL 60015, USA Phone:
More informationClinical Review Report (Sample)
CADTH COMMON DRUG REVIEW Clinical Review Report (Sample) GENERIC DRUG NAME (BRAND NAME) (Manufacturer) Indication: Text Disclaimer: The information in this document is intended to help Canadian health
More informationHOUSING AUTHORITY OF THE CITY AND COUNTY OF DENVER REASONABLE ACCOMMODATION GRIEVANCE PROCEDURE
HOUSING AUTHORITY OF THE CITY AND COUNTY OF DENVER REASONABLE ACCOMMODATION GRIEVANCE PROCEDURE I. DEFINITIONS (A) Complainant: Any Tenant (as defined below) whose grievance is presented to the 504 Coordinator
More informationTitle 22: HEALTH AND WELFARE
Title 22: HEALTH AND WELFARE Chapter 262: SMOKING Table of Contents Subtitle 2. HEALTH... Part 3. PUBLIC HEALTH... Section 1541. DEFINITIONS... 3 Section 1542. SMOKING PROHIBITED IN PUBLIC PLACES... 4
More informationLIFEPROOF LIMITED WARRANTY TOTAL WATER PROTECTION PROGRAM TERMS AND CONDITIONS
LIFEPROOF LIMITED WARRANTY TOTAL WATER PROTECTION PROGRAM TERMS AND CONDITIONS Otter Products, LLC, doing business as LifeProof, and its affiliated companies worldwide (collectively, LifeProof ) warrants
More informationRef: E 007. PGEU Response. Consultation on measures for improving the recognition of medical prescriptions issued in another Member State
Ref:11.11.24E 007 PGEU Response Consultation on measures for improving the recognition of medical prescriptions issued in another Member State PGEU The Pharmaceutical Group of the European Union (PGEU)
More informationBiobank sustainability: preliminary survey results on the level of business planning in UK biobanks
Biobank sustainability: preliminary survey results on the level of business planning in UK biobanks Kirstin Goldring Principal Scientist HBS Strategy and Governance UK Biobanking Showcase 2017 18 th October
More information1.) In which region of the world is your firm's headquarters/main office located? (If more than one, indicate only the primary location.
East Asia & Pacific 85 Europe & Central Asia 225 Latin America & the Caribbean 91 Middle East & North Africa 24 North America 453 South Asia 25 Sub Saharan Africa 17 1.) In which region of the world is
More informationTo provide information on the new standard, a number of EOG members formed a committee to compile information on the following basis:
EN 13537 Sleeping Bag Standard Information for Retailers 30.12.2004 Disclaimer This information sheet has been provided by the EOG to help companies assess the implications of the new EN 13537 norm on
More informationIAF Mandatory Document. Requirements for the Migration to ISO 45001:2018 from OHSAS 18001:2007 (IAF MD 21:2018)
IAF Mandatory Document Requirements for the Migration to ISO 45001:2018 from OHSAS 18001:2007 Issue 1 (IAF MD 21:2018) Issue 1 Requirements for the Migration to Page 2 of 12 The (IAF) facilitates trade
More informationSenator Mark B. Madsen proposes the following substitute bill:
LEGISLATIVE GENERAL COUNSEL 6 Approved for Filing: S.C. Johnston 6 6 03-03-15 4:49 PM 6 S.B. 259 2nd Sub. (Salmon) Senator Mark B. Madsen proposes the following substitute bill: 1 MEDICAL CANNABIS AMENDMENTS
More informationBEWARE! Global Regulatory Trends Undermining the Future of Brands
BEWARE! Global Regulatory Trends Undermining the Future of Brands Big Tobacco, Big Food, Big Soda, Big Alcohol: It s not just us saying so! Big Tobacco, Big Food, Big Soda, Big Alcohol: It s not just us
More informationCHILD AND ADULT CARE FOOD PROGRAM ADMINISTRATIVE REVIEW PROCEDURES
CHILD AND ADULT CARE FOOD PROGRAM ADMINISTRATIVE REVIEW PROCEDURES The regulations and guidelines of the Child and Adult Care Food Program (CACFP or Program) under the Food and Nutrition Service (FNS)
More informationBritish American Tobacco Snus Marketing Standards
British American Tobacco Snus Marketing Standards British American Tobacco p.l.c. believes there is sufficient scientific evidence to support a less restrictive regime for the advertising and promotion
More informationon the advertising of medicinal products for human use
30. 4. 92 Official Journal of the European Communities No L 113 / 13 COUNCIL DIRECTIVE 92/28/EEC of 31 March 1992 on the advertising of medicinal products for human use THE COUNCIL OF THE EUROPEAN COMMUNITIES,
More informationUnited Kingdom. Contributing firm Edwards Wildman Palmer LLP. Author Colin Sawdy and Gemma Boore
United Kingdom Contributing firm Edwards Wildman Palmer LLP Author Colin Sawdy and Gemma Boore Selection, clearance and registration Trademarks in the United Kingdom are governed by the Trademarks Act
More informationImplantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter
Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), and Cardiac Resynchronization
More informationINCORPORATED COUNTY OF LOS ALAMOS ADMINISTRATIVE PROCEDURE GUIDELINE
INCORPORATED COUNTY OF LOS ALAMOS ADMINISTRATIVE PROCEDURE GUIDELINE Index No. 1736 Effective: July 1, 2000 Revised: August 20, 2014 I. Purpose SALE, SERVICE AND CONSUMPTION OF ALCOHOLIC BEVERAGES AT COUNTY
More informationCase 2:12-cv LRH-GWF Document 1 Filed 08/24/12 Page 1 of 26
Case :-cv-0-lrh-gwf Document Filed 0// Page of South th Street Second Floor Las Vegas, Nevada 0 Tel: (0) - Fax: (0) - 0 COMP PUOY K. PREMSRIRUT, Esq. Nevada Bar No. 00 S. Fourth Street, Second Floor Las
More informationTobacco Insights May
Tobacco Insights 2015 - May Product Code: TI0017MR Published Date: June 2015 Report Price: US$ 150 (Single Copy) Synopsis Tobacco Insights 2015 - May report is a qualitative report providing extensive
More informationGrant Application for Individuals
Grant Application for Individuals Thank you for your interest in applying for a grant from Small Steps in Speech, a nonprofit 501(c)3 foundation created in memory of Staff Sgt. Marc J. Small. The Board
More informationEmployment Contract. This sample employment contract is from Self-Employment vs. Employment Status, CDHA (no date available)
Employment Contract This sample employment contract is from Self-Employment vs. Employment Status, CDHA (no date available (NOTE: This is only one example of an employment contract. This example is meant
More information